AstraZeneca

Life Sciences Update -- May 2013: Baker & McKenzie

Increased Regulation of Interactions with Healthcare Professionals - In an effort to increase the transparency of interactions between pharmaceutical companies and health care professionals the new (17th) edition of...more

Conflicting Results from Ontario Appellate Courts in Motions to Strike Claims in Proposed Class Actions

Ontario’s appellate courts have released two decisions in the past week addressing the issue of when claims ought to be struck in the context of proposed class proceedings for failing to disclose a cause of action. First, a...more

In re Rosuvastatin Calcium Patent Litigation (Fed. Cir. 2012)

Late last year, in AstraZeneca v. Aurobindo (In re Rosuvastatin Calcium Patent Litigation), the Federal Circuit affirmed that a reissue patent covering the active ingredient of Crestor® was valid, enforceable, and infringed...more

Antitrust and Life Sciences Alert: EU Court of Justice Hears Appeal of Abuse of Dominance Finding Against AstraZeneca

On 12 January 2012, the Court of Justice of the European Union heard AstraZeneca's appeal of the General Court's judgment largely upholding the European Commission's decision fining AstraZeneca €60 million for abuse of...more